This disclosure relates to regenerative medicine and particularly to a surgical implant procedure and device for the enhancement and appearance of the human penis, and more particularly to a penile implant enabling a non-functioning penis to fulfill normal sexual function. A patent, U.S. Pat. No. 6,537,204 was issued to James Elist on Mar. 25, 2003 for a similar implant and the subject matter of this patent is incorporated by reference hereinto in its entirety. The presently described implant of this disclosure advances the state of the art over the '204 references as will be described herein.
Regenerative medicine is the process of replacing or regenerating human cells, tissues or organs to restore or establish normal function. This field holds the promise of regenerating damaged tissues and organs in the body by replacing damaged tissue and/or by stimulating the body's own repair mechanisms to heal previously irreparable tissues or organs. Regenerative medicine refers to a group of biomedical approaches to clinical therapies that may involve the use of stem cells and implantation devices as well as other approaches. Examples include the injection of stem cells or progenitor cells (cell therapies); the induction of regeneration by biologically active molecules administered alone or as a secretion by infused cells and transplantation of in-vitro grown organs and tissues. For example, in abdominal wall reconstruction such as inguinal hernia repair, biologic meshes have been used successfully. When an organ, such as the human penis, is physically damaged or becomes functionally impotent, the implantation of structural elements is sometimes desirable. A prior known approach is disclosed in U.S. Pat. No. 6,537,204, Mar. 25, 2003, to the present discloser and is hereby incorporated in its entirety herein. The present application discloses and claims certain non-obvious and novel, critical improvements as will be described and shown herein.